Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? a qualitative study

BACKGROUND: The treatment of cancer associated thrombosis (CAT) is well established, with level 1A evidence to support the recommendation of a low molecular weight heparin (LMWH) by daily injection for 3–6 months. However, registry data suggest compliance to clinical guidelines is poor. Clinicians f...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Miriam J, Sheard, Laura, Maraveyas, Anthony, Noble, Simon, Prout, Hayley, Watt, Ian, Dowding, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445826/
https://www.ncbi.nlm.nih.gov/pubmed/22818215
http://dx.doi.org/10.1186/1472-6947-12-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445826/
https://www.ncbi.nlm.nih.gov/pubmed/22818215
http://dx.doi.org/10.1186/1472-6947-12-75

Ejemplares similares